🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

Beam Therapeutics clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, UK and Ireland registers with Beam Therapeutics as lead sponsor. Synced 26 Sep 2026
6Current trials
4Recruiting now
0Drugs in these trials
3Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

Beam Therapeutics is the lead sponsor of 6 current clinical trials in our USA, UK and Ireland registers. 4 are recruiting patients now. The most common phase is Phase 1/2. The most-studied condition is Sickle Cell Disease.

ClinicalTrials.gov trials by status

  • Recruiting467%
  • Active, closed233%

Trials by phase

  • Phase 1/2467%
  • Phase 1117%
  • Observational117%
01

Clinical trials sponsored by Beam Therapeutics

6 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
NCT06389877 · Alpha 1-Antitrypsin Deficiency
Phase 1/2 Recruiting 2024-06 Ireland, UK, USA
This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects
NCT07304791 · ClinicalTrials.gov ↗ · Healthy Subjects, Healthy Participant Study
Phase 1 Recruiting 2025-10 UK
A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)
NCT06735755 · ClinicalTrials.gov ↗ · Glycogen Storage Disease Type Ia
Phase 1/2 Recruiting 2024-12 USA
A Long-term Follow-up Study in Patients Who Received BEAM-101
NCT07373639 · ClinicalTrials.gov ↗ · Hemoglobinopathy, Sickle Cell Disease
Observational Recruiting 2025-12 USA
BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell Disease
NCT05456880 · ClinicalTrials.gov ↗ · Sickle Cell Disease
Phase 1/2 Active, closed 2022-08 USA
A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)
NCT05885464 · ClinicalTrials.gov ↗ · Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia
Phase 1/2 Active, closed 2023-05 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Beam Therapeutics trials

9 conditions
Sickle Cell Disease2Alpha 1-Antitrypsin Deficiency1Healthy Subjects1Healthy Participant Study1Glycogen Storage Disease Type Ia1Hemoglobinopathy1Lymphoblastic Lymphoma1T-Cell Lymphoblastic Leukemia/Lymphoma1Lymphoblastic Leukemia1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in USA53
Clinical trials in UK22
Clinical trials in Ireland11

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Sickle Cell Disease

SponsorTrials
Agios Pharmaceuticals4
Forma Therapeutics3
Genetix Biotherapeutics2
Editas Medicine2
CSL Behring1

Sponsors with the most current trials registered for this condition.

05

Questions about Beam Therapeutics trials

How many clinical trials does Beam Therapeutics sponsor?

Beam Therapeutics is the lead sponsor of 6 current trials on ClinicalTrials.gov in our USA, UK and Ireland registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are Beam Therapeutics trials recruiting?

Yes. 4 of its 6 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Does Beam Therapeutics have clinical trials in Ireland?

Yes. 1 trial in our Ireland register (ClinicalTrials.gov). Some may be the same study registered in both. See the Irish clinical trials register for sites and contacts.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.